oxybutynin has been researched along with Tobacco Use Disorder in 11 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Tobacco Use Disorder: Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 6.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| "We previously reported short-term results from a perioperative randomized controlled trial comparing usual care with an intervention involving (1) brief counseling by the preadmission nurse, (2) smoking cessation brochures, (3) referral to a telephone quitline, and (4) a free 6-week supply of transdermal nicotine replacement." | 5.20 | Long-term quit rates after a perioperative smoking cessation randomized controlled trial. ( Buhrmann, O; Jones, PM; Landry, J; Lee, SM; Morley-Forster, P, 2015) |
| "Participants (N = 365) in a larger smoking cessation clinical trial completed the modified Simon task twice (while 10-h nicotine-deprived vs." | 5.15 | Cognitive conflict following appetitive versus negative cues and smoking cessation failure. ( Baker, TB; Curtin, JJ; Gloria, R; Japuntich, SJ; Piper, ME; Schlam, TR, 2011) |
| "Using baseline data from a randomized clinical trial to examine the efficacy of selegiline for cigarette smoking cessation (n = 280), we conducted univariate analyses (analysis of variance or chi-square) to determine statistically significant predictors of a successful quit attempt (SQA) versus unsuccessful quit attempt." | 5.15 | Predicting successful 24-hr quit attempt in a smoking cessation intervention. ( Bailey, SR; Bryson, SW; Killen, JD, 2011) |
| "Fixed-dose nicotine replacement therapy (NRT) is efficacious for smoking cessation in the general population of smokers." | 3.79 | Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. ( Andriash, K; Busto, UE; Persad, D; Selby, P; Zack, M; Zawertailo, L, 2013) |
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 2.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| "The nicotine patch was the most commonly used form of NRT." | 1.37 | Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. ( Aveyard, P; Beard, E; Fidler, J; McNeill, A; Michie, S; West, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Struble, RD | 1 |
| Knox, BA | 1 |
| Richter, KP | 1 |
| Ellerbeck, EF | 1 |
| Bernstein, SL | 2 |
| Dziura, J | 1 |
| Weiss, J | 1 |
| Miller, T | 1 |
| Vickerman, KA | 1 |
| Grau, LE | 1 |
| Pantalon, MV | 1 |
| Abroms, L | 1 |
| Collins, LM | 1 |
| Toll, B | 1 |
| Baldassarri, SR | 1 |
| Chupp, GL | 1 |
| Slade, MD | 1 |
| Fucito, LM | 1 |
| Toll, BA | 1 |
| Selby, P | 1 |
| Andriash, K | 1 |
| Zawertailo, L | 1 |
| Persad, D | 1 |
| Zack, M | 1 |
| Busto, UE | 1 |
| Burns, EK | 1 |
| Hood, NE | 1 |
| Goforth, E | 1 |
| Levinson, AH | 1 |
| Lee, SM | 1 |
| Landry, J | 1 |
| Jones, PM | 1 |
| Buhrmann, O | 1 |
| Morley-Forster, P | 1 |
| De Ruyck, K | 1 |
| Nackaerts, K | 1 |
| Beels, L | 1 |
| Werbrouck, J | 1 |
| De Volder, A | 1 |
| Meysman, M | 1 |
| Salhi, B | 1 |
| Van Meerbeeck, J | 1 |
| Thierens, H | 1 |
| Schlam, TR | 1 |
| Japuntich, SJ | 1 |
| Piper, ME | 1 |
| Gloria, R | 1 |
| Baker, TB | 1 |
| Curtin, JJ | 1 |
| Beard, E | 1 |
| McNeill, A | 1 |
| Aveyard, P | 1 |
| Fidler, J | 1 |
| Michie, S | 1 |
| West, R | 1 |
| Clark, SM | 1 |
| Nakad, R | 1 |
| Bailey, SR | 1 |
| Bryson, SW | 1 |
| Killen, JD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimizing Tobacco Dependence Treatment in the Emergency Department[NCT02896400] | Phase 3 | 1,056 participants (Actual) | Interventional | 2017-02-13 | Completed | ||
| Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation[NCT00289653] | 23 participants (Actual) | Interventional | 2005-09-30 | Completed | |||
| A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline[NCT01889771] | 1,495 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| The Effect of a Perioperative Smoking Cessation Program on Rates of Smoking Cessation/Reduction and Perioperative Complications: a Randomized Clinical Trial.[NCT01260233] | 168 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Abstinence self reported and verified by exhaled carbon monoxide (NCT02896400)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Brief Negotiated Interview (BNI) | 71 |
| Brief Negotiated Interview (BNI) CONTROL | 49 |
| Nicotine Replacement Therapy (NRT) | 76 |
| Nicotine Replacement Therapy (NRT) CONTROL | 44 |
| Quitline (QL) | 66 |
| Quitline (QL) CONTROL | 54 |
| Text | 61 |
| Text CONTROL | 59 |
Expired Co levels were measured to confirm smoking status (NCT00289653)
Timeframe: measured at week 10
| Intervention | parts per million (Mean) |
|---|---|
| Enrolled Participants | 9.2 |
self reported # cigarettes per day (NCT00289653)
Timeframe: Week 10
| Intervention | cigarettes per day (Mean) |
|---|---|
| Enrolled Participants | 3.7 |
1 review available for oxybutynin and Tobacco Use Disorder
| Article | Year |
|---|---|
Pharmacotherapeutic management of nicotine dependence in pregnancy.
Topics: Female; Humans; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2011 |
6 trials available for oxybutynin and Tobacco Use Disorder
| Article | Year |
|---|---|
Tobacco dependence treatment in the emergency department: A randomized trial using the Multiphase Optimization Strategy.
Topics: Adult; Cost-Benefit Analysis; Emergency Service, Hospital; Female; Hotlines; Humans; Male; Middle Ag | 2018 |
Randomised trial of two nicotine patch protocols distributed through a state quitline.
Topics: Administration, Cutaneous; Adolescent; Adult; Cost-Benefit Analysis; Drug Costs; Female; Government | 2016 |
Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Health Behavior; Health Knowledge, Attitudes, | 2015 |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catechol O-Methyltransferase; Double-Blind Method; Femal | 2010 |
Cognitive conflict following appetitive versus negative cues and smoking cessation failure.
Topics: Adult; Appetitive Behavior; Cognition Disorders; Conflict, Psychological; Cues; Dose-Response Relati | 2011 |
Predicting successful 24-hr quit attempt in a smoking cessation intervention.
Topics: Adult; Behavior Therapy; Double-Blind Method; Female; Follow-Up Studies; Health Promotion; Humans; L | 2011 |
4 other studies available for oxybutynin and Tobacco Use Disorder
| Article | Year |
|---|---|
Insurance coverage and utilization of nicotine patches after receipt of a prescription.
Topics: Aged; Female; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Male; Medicaid; Medica | 2020 |
Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
Topics: Adult; Counseling; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Middl | 2018 |
Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Topics: Administration, Cutaneous; Adult; Affect; Behavior, Addictive; Biomarkers; Carbon Monoxide; Comorbid | 2013 |
Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers.
Topics: Adult; Age Factors; Chewing Gum; England; Female; Harm Reduction; Health Knowledge, Attitudes, Pract | 2011 |